Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
We break down Which Index Funds To Buy For Retirement 2024, focusing on costs, diversification, and track records to help you decide.
24,904 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Regional banks sit at the intersection of local ties and global markets. This regional bank survival guide explains h...
Quantum computing could reshape industries, and early investors may gain. This guide breaks down three stocks to watc...
The IEA just revised demand down by 420,000 barrels per day, signaling slower consumption ahead. This shift could res...
When a prominent fund makes a sizable stake reduction, it often signals more than profit-taking. This article breaks ...
As Treasury yields rise, a clearer message is emerging for investors: borrowing costs are up, risk appetites tilt, an...
Morgan Stanley filed amended SEC registrations for Ethereum and Solana ETFs, proposing a 14-basis-point sponsorship f...
GLD's fee drag and tax treatment can erode bullion gains even as gold prices rise. A closer look at cheaper peers and...
A deceptive text claiming an Apple charge can spark a dangerous cash-loss scam against seniors. Learn how the fake ap...
A Michigan father received a frightening call about his son being in jail. He paid $5,500 with gift cards, unaware th...
A major fund exits a Buckle stake, triggering questions about strategy and market signals. This article breaks down w...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...